Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning

Transfusion

Volumn 47, Issue 8, 2007, Pages 1494-1502

  Worel, Nina ^a   Greinix, Hildegard T ^a   Supper, Volker ^a   Leitner, Gerda ^a   Mitterbauer, Margit ^a   Rabitsch, Werner ^a   Fischer, Gottfried ^a   Rosenmayr, Agathe ^a   Höcker, Paul ^a   Kalhs, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; FATALITY; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMOLYSIS; HUMAN; HYPOTENSION; IMMUNOPATHOLOGY; INCIDENCE; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROPHYLAXIS; REDUCED INTENSITY CONDITIONING;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; BLOOD GROUP INCOMPATIBILITY; ERYTHROCYTE TRANSFUSION; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; GRAFT VS HOST DISEASE; HEMOLYSIS; HUMANS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 34547112801     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01289.x     Document Type: Article

References (21)

1. Sniecinski IJ, Oien L, Petz LD, Blume KG. Immunohematologic consequences of major ABO-mismatched bone marrow transplantation. Transplantation 1988 45 : 530 3.
2. Bornhauser M, Ordemann R, Paaz U, et al. Rapid engraftment after allogeneic ABO-incompatible peripheral blood progenitor cell transplantation complicated by severe hemolysis. Bone Marrow Transplant 1997 19 : 295 7.
3. Bolan CD, Childs RW, Procter JL, Barrett AJ, Leitman SF. Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility. Br J Haematol 2001 112 : 787 95.
4. Worel N, Greinix G, Keil F, et al. Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning. Transfusion 2002 42 : 1293 301.
5. Hansen JA, Mickelson EM, Choo SY, et al. Clinical bone marrow transplantation. Donor selection and recipient monitoring. In : Rose NR, De Macario EC, Fahey JL, Friedman H, Penn GM, editors. Manual of clinical laboratory immunology. Washington (DC) : American Society for Microbiology 1992. p. 8 50.
6. Fischer GF, Faé I, Petrasek M, Moser S. A combination of two distinct in vitro amplification procedures for DNA typing of HLA-DRB and -DQB1 alleles. Vox Sang 1995 69 : 328 35.
7. Greinix HT, Faé I, Schneider B, et al. Impact of HLA class I high-resolution mismatch on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors. Bone Marrow Transplant 2005 35 : 57 62.
8. McSweeney PA, Niederwieser D, Shizuru JA, et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001 97 : 3390 400.
9. Schmid C, Schleuning M, Schwerdtfeger R, et al. Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation. Blood 2006 108 : 1092 9.
10. Cull GM, Haynes AP, Byrne JL, et al. Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorder using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity. Br J Haematol 2000 108 : 754 60.
11. Dreger P, Brand R, Hansz J, et al. Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning. Leukemia 2003 17 : 841 8.
12. Winston DJ, Gale RP. Prevention and treatment of cytomegalovirus infection and disease after bone marrow transplantation in the 1990s. Bone Marrow Transplant 1991 8 : 7 11.
13. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995 15 : 825 8.
14. Sullivan KM, Shulman HM, Storb R, et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981 57 : 267 76.
15. Keil F, Haas OA, Fritsch G, et al. Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: lack of residual donor hematopoiesis predicts aplasia. Blood 1997 89 : 3113 7.
16. Widman FK, editor. Technical manual. 9th ed. Arlington (VA) : American Association of Blood Banks 1985.
17. Lapierre Y, Rigal D, Adam D, et al. The gel test: a new way to detect red cell antigen-antibody reactions. Transfusion 1990 30 : 109 13.
18. Mielcarek M, Zaucha JM, Sandmaier B, et al. Type of post-grafting immunosuppression after non-myeloablative blood cell transplantation may influence risk of delayed haemolysis due to minor ABO incompatibility. Br J Haematol 2002 116 : 500 1.
19. Giaccone L, McCune JS, Maris MB, et al. Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation. Blood 2005 106 : 4381 8.
20. Klumpp TR, Herman JH, Ulicny J, Rmmond TB, Martin ME, Mangan KF. Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation. Transfusion 2006 38 : 615 20.
21. Petz LD. Hemolysis associated with transplantation [editorial]. Transfusion 1998 38 : 224 8.